Scleroderma Clinical Research and Trials
Our patients have the opportunity to participate in a wide variety of clinical trials of novel therapies. Physicians in the Program are active in trial development and design. Recent examples have included trials of agents to treat pulmonary hypertension, digital ulcers, lung disease, skin fibrosis and overall disease therapy. We are also actively enrolling interested patients in a variety of ongoing studies to assess clinical and biologic outcomes in scleroderma. Our program is an active member of the Scleroderma Clinical Trials Consortium (SCTC), an international group that conducts multicenter trials of therapies in scleroderma. Members of the Section hold leadership positions in the SCTC. Our clinical programs also serve as important educational hub for other physicians and trainees to enhance awareness and clinical care in scleroderma.
Active trials change frequently, so please contact us directly for questions about enrolling trials.